Aclaris Therapeutics, Inc. (Nasdaq: ACRS) to Ring The

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Aclaris Therapeutics, Inc. (Nasdaq: ACRS) to Ring The Nasdaq Stock Market Closing Bell

ADVISORY, July 25, 2016 (GLOBE NEWSWIRE) --

What:  Aclaris Therapeutics, Inc. (Nasdaq: ACRS ), a clinical-stage specialty pharmaceutical company, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, Dr. Neal Walker, President and CEO , will ring the Closing Bell. 

Where: Nasdaq MarketSite – 4 Times Square – 43 rd & Broadway – Broadcast Studio

When: Tuesday, July 26, 2016 – 3:45 p.m. to 4:00 p.m. ET       

Aclaris Therapeutics Media Contact: Laura Morgan (347) 342-8496 l.morgan@togorun.com  

Nasdaq MarketSite: Emily Pan (646) 441-5120 emily.pan@nasdaq.com

Feed Information: Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK

Social Media: For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: http://www.facebook.com/NASDAQ .

For photos from ceremonies and events, please visit our Instagram page: http://instagram.com/nasdaq

For livestream of ceremonies and events, please visit our YouTube page: http://www.youtube.com/nasdaq/live

For news tweets, please visit our Twitter page: http://twitter.com/nasdaq

For exciting viral content and ceremony photos, please visit our Tumblr page: http://nasdaq.tumblr.com/

Webcast: A live stream of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos: To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice.

About Aclaris Therapeutics Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology.  Aclaris Therapeutics, Inc. is based in Malvern, Pennsylvania and more information can be found by visiting the company’s website at http://www.aclaristx.com/ .

About Nasdaq Nasdaq (Nasdaq: NDAQ ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.3 trillion and nearly 17,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

-NDAQA-

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Solink Secures $100M: NYSE Sees Tech and Sports Moves

Updated Category News Views 51

Folks, it’s a busy day on Wall Street, with Solink leading the charge by landing over a cool $100 million in fresh funding. Let's break this down because when startups pocket nine-digit figures, it's time to pay attention. Solink's Leap Forward Now, what’s Solink doing with all that cash? They're not scrambling for coffee money, that's for sure. Instead, this funding...

Continue Reading
Yulin Dog Meat Ban: A Milestone in Animal Rights

Updated Category News Views 51

Shockwaves from Yulin: A Landmark Victory Out of the blue, the news from Yulin is stirring emotions worldwide. All dog slaughterhouses in Yulin, a city notorious for its gruesome dog meat festival, have been reportedly demolished. The city plans to impose a ban on dog meat, a radical shift unimaginable a decade ago. For animal rights advocates, it's an invigorating shot...

Continue Reading
Milwaukee Art Museum Secures $10 Million Preservation Fund

Updated Category News Views 68

In a world where art meets aspiration, the Quadracci family’s latest $10 million gift to the Milwaukee Art Museum speaks volumes. With a vision to guarantee the future of architectural elegance, they’re making sure Santiago Calatrava’s stunning Quadracci Pavilion remains a cornerstone on Milwaukee’s skyline. For twenty-five years, this striking creation has not...

Continue Reading
RPC Reports Q3 Loss Amid Revenue Growth Quirks

Updated Category News Views 48

RPC Rides Out a Rough Quarter with Strategic Moves Ah, the oilfield services game—never a dull moment, right? RPC, Inc. just dropped their Q3 2026 results, and there’s a mixed bag to digest here. On the one hand, they saw a modest 1% uptick in revenue, hitting $467.7 million. But on the flip side, they're grappling with a hefty net loss of $41.9 million thanks to a...

Continue Reading
DayOne's Bold Energy Moves With Sembcorp for Asia Growth

Updated Category News Views 68

It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...

Continue Reading
Corgi Revamps Malpractice Insurance for Healthcare Sector

Updated Category News Views 127

Streamlining Insurance for Healthcare Professionals Here's one for the books in the insurance world: Corgi Insurance is stepping up to spare healthcare practices from the headache of getting medical malpractice coverage. This is more than just insurance talk; it's about time someone carved out a path through the labyrinth of medical malpractice policies. Healthcare folks...

Continue Reading
Max Stock Gears Up for Q3 Earnings Report Nov. 17

Updated Category News Views 28

Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...

Continue Reading
ACCULOAD: Aiming for Safer, Easier Boat Loading

Updated Category News Views 0

Getting a boat onto a trailer? It can turn into a circus act if you're not careful. Visibility's shot, conditions change faster than a stock ticker, and alignment's like threading a needle blindfolded. Out comes ACCULOAD, a novel idea created by some intrepid inventor down in Slocomb, Ala, aiming to solve what’s been a pain point for boaters worldwide. What's ACCULOAD...

Continue Reading
xTool X1: Redefining Laser Fabrication for Makers

Updated Category News Views 108

The Next Generation of Laser Fabrication Whenever a new gizmo hits the market, it's usually just an upgrade in disguise—faster, shinier, a touch more wattage. Not this time. xTool shook things up by rolling out the X1, a laser platform that gets what small businesses and makers truly crave: versatility and long-lasting potential. This bad boy does more than engrave; it...

Continue Reading
White House Photographer Reveals Unseen Historic Moments

Updated Category News Views 118

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Continue Reading

Top 5 Most Recently Viewed Articles

Kroger Welcomes New CEO Greg Foran to Lead Retail Growth

Updated Category News Views 137

Kroger Welcomes New Leadership with Greg Foran as CEO Kroger Co. has exciting news to share as it appoints Greg Foran as its new Chief Executive Officer. This strategic move is seen as pivotal for the company's continued growth trajectory. Foran, an esteemed figure in the retail sector, assumes his role immediately and will also join Kroger's Board of Directors. He takes...

Continue Reading
Subsea 7 S.A. Updates on Shareholder Transactions

Updated Category News Views 86

Understanding Recent Shareholder Notifications for Subsea 7 S.A. Subsea 7 S.A. remains committed to transparency and compliance with EU Market Abuse Regulation. Recently, the company received important notifications regarding share transactions made by a significant shareholder. This proactive announcement reflects the company's dedication to keeping stakeholders informed...

Continue Reading
Roche Unveils Advanced Pharma Research Center to Propel Innovation

Updated Category News Views 131

Roche opens new Pharma Research and Early Development Center in Basel Roche has opened a new Pharma Research and Early Development (pRED) Center at its headquarters in Basel. The facility marks a concrete step in the company’s effort to turn strong science into medicines that reach patients, reinforcing a commitment Roche has upheld for more than a century. A hub for...

Continue Reading
Peter Lilienthal Brings Expertise to Xendee as New Advisor

Updated Category News Views 127

Pioneering Energy Solutions: Dr. Peter Lilienthal Joins Xendee In an exciting development for the energy sector, Xendee Corporation has welcomed Dr. Peter Lilienthal as a new advisor. Known for his extensive background in hybrid renewable energy and microgrid systems, Dr. Lilienthal's experience spans over 40 years and includes significant contributions to various...

Continue Reading
Xeris Biopharma Anticipates Record Revenue Growth for 2024

Updated Category News Views 130

Xeris Biopharma Anticipates Solid Revenue Growth for 2024 Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) recently shared positive developments regarding its financial outlook for the year ahead. The company expects total revenues to reach an impressive $203 million in 2024, surpassing its prior guidance that estimated revenues between $198 million and $202 million. This...

Continue Reading